Published online Jun 7, 2015. doi: 10.3748/wjg.v21.i21.6759
Peer-review started: November 9, 2014
First decision: November 26, 2014
Revised: December 10, 2014
Accepted: February 5, 2015
Article in press: February 5, 2015
Published online: June 7, 2015
Processing time: 217 Days and 21.6 Hours
We report the case of a 69-year-old woman with reactive lymphoid hyperplasia (RLH) of the liver. She underwent partial hepatectomy under a preoperative diagnosis of hepatocellular carcinoma; however, histopathological analysis revealed RLH. The liver nodule showed the imaging feature of perinodular enhancement in the arterial dominant phase on contrast-enhanced computed tomography and magnetic resonance imaging, which could be a useful clue for identifying RLH in the liver. Histologically, the perinodular enhancement was compatible with prominent sinusoidal dilatation surrounding the liver nodule.
Core tip: It is difficult to differentiate between reactive lymphoid hyperplasia (RLH) of the liver and malignant liver tumors such as hepatocellular carcinoma and liver metastases. We observed a liver nodule with perinodular enhancement in the arterial dominant phase on contrast-enhanced computed tomography and magnetic resonance imaging. We consider that this imaging feature could be a useful clue for identifying RLH in the liver. Histological analysis revealed the liver nodule in our patient to be RLH, with prominent sinusoidal dilatation around the nodule. This dilatation is the cause of the perinodular enhancement, which is useful for the accurate diagnosis of RLH.
